Related Experiment Videos

Pyrin/marenostrin mutations in familial Mediterranean fever

D R Booth1, J D Gillmore, S E Booth

  • 1Immunological Medicine Unit, Imperial College School of Medicine, Hammersmith Hospital, London, UK.

Insights

Familial Mediterranean fever (FMF) genetic testing identifies mutations in the pyrin/marenostrin gene. Genotyping is a valuable diagnostic tool for FMF, aiding in the diagnosis of this inherited inflammatory disease.

Area of Science:

  • Genetics
  • Immunology
  • Internal Medicine

Background:

  • Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder.
  • FMF is often complicated by reactive systemic amyloidosis (AA amyloidosis).
  • Pyrin/marenostrin gene mutations are strongly linked to FMF.

Purpose of the Study:

  • To investigate the genetic basis of FMF in a diverse patient cohort.
  • To correlate pyrin/marenostrin genotypes with FMF clinical phenotypes and AA amyloidosis.
  • To evaluate the diagnostic utility of pyrin/marenostrin genotyping in FMF.

Main Methods:

  • Studied 27 patients with classical, probable, or possible FMF.
  • Determined pyrin/marenostrin genotypes.
  • Assessed for AA amyloidosis using serum amyloid P component scintigraphy.

Main Results:

  • Identified pyrin/marenostrin mutations in most FMF patients, with 17/23 classical/probable FMF patients being homozygotes or compound heterozygotes.
  • Discovered two new mutations (T6811 and delta M694).
  • Found AA amyloidosis in nine patients, independent of specific genotype; no mutations were found in three of four possible FMF patients.

Conclusions:

  • Pyrin/marenostrin genotyping is a valuable diagnostic test for FMF.
  • Most FMF patients carry mutations in both pyrin/marenostrin alleles.
  • Clinical interpretation of genotype results is crucial, as unidentified second mutations may occur.

Related Concept Videos